Laurion Capital Management LP Opti Nose, Inc. Transaction History

Laurion Capital Management LP

  • $5.23 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$3.2 - $4.98 $134,915 - $209,961
-42,161 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$3.69 - $7.09 $155,574 - $298,921
42,161 New
42,161 $164,000

Others Institutions Holding OPTN

# of Institutions
9
Shares Held
52.9M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $500M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email